bioRxivImmunology
Hepatitis B mother-to-child transmission in the Eastern Region of Ghana: A cross-sectional pilot study
Abstract
BackgroundHepatitis B is a major health concern in Ghana, where prevalence of the virus remains high and most chronic patients are infected during childhood or at birth. There are several factors which can influence transmission risk from an infected mother to her infant, such as the presence of viral markers, the viral load and the use of prophylactic interventions. It is therefore important to determine the prevalence and main factors associated with mother-to-child transmission of hepatitis B in the context of Ghana.\n\nMaterials and methodsIn this cross-sectional pilot study, hepatitis B testing was performed on infants born to infected mothers at a single site in the Eastern Region of Ghana. Test results were matched to a questionnaire which consisted of variables related to pregnancy and birth conditions. This was primarily a descriptive study to determine the prevalence of hepatitis B mother-to-child transmission as well as the preventive interventions and diagnostic methods used. The study variables were also analysed independently using Fishers exact test, while mothers age at the time of delivery was assessed using univariate logistic regression.\n\nResultsA total of 51 cases were included in the study and three (5.9%) of the infants tested positive. No significant association was observed between mothers age and mother-to-child transmission (OR: 1.077, 95% CI: 0.828 - 1.403, p=0.58). A majority of infants received the standard hepatitis B vaccination schedule (96.1%) while two-thirds received the birth dose. There was no significant association observed between the clinical interventions reported in the study and mother-to-child transmission. Testing for viral markers and the use of antiviral therapy during pregnancy were absent in the population and could not be reliably assessed.\n\nConclusionThere was a low prevalence of HBV mother-to-child transmission observed despite a clear absence of viral marker and viral load testing. It is recommended that viral profile analysis is performed for hepatitis B positive pregnancies to identify high risk cases.
- organism: human
- assay: clinical cohort / trial
- research focus: host-pathogen & immune response
- approach: statistical model
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Hepatitis B cell-free DNA in non-invasive prenatal testing as an early biomarker of viral infectivity
Vu Dao, Phuc Tri Nguyen, … Minh‐Duy Phan·medRxiv·Aug 21, 2026
- Hepatitis E as a cause of adult hospitalization in Bangladesh: Results from an acute jaundice surveillance study in six tertiary hospitals, 2014-2017
R. Paul, A. Nazneen, … E. S. Gurley·bioRxiv·Jul 2, 2019
- Acute Hepatitis E Virus infection in two geographical regions of Nigeria
I. M. Ifeorah, T. O. C. Faleye, … J. A. Adeniji·bioRxiv·Aug 20, 2017
- Epidemiological impact of hepatitis B vaccination in Monastir Tunisia (2000-17)
Wafa Dhouib, Meriem Kacem, … Asma Sriha Belguith·bioRxiv·Aug 6, 2018
- Detection the Prevalence of Hepatitis C Virus among Iraqi People
H. A. A. Khudhair, A. A. H. Albakaa, K. R. Hussein·bioRxiv·Nov 28, 2020
- HBV vaccination and PMTCT as elimination tools in the presence of HIV: insights from a clinical cohort and dynamic model
A. McNaughton, J. Lourenco, … P. C. Matthews·bioRxiv·Sep 24, 2018